169159 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
BIOMARKER FOR DIAGNOSIS OF GASTRIC CANCER
#2METHODS OF DETECTING DDR1 PHOSPHORYLATION
#3SCREENING MODELS AND METHODS OF CANCER TREATMENT
#4NON-RADIOACTIVE CYTOTOXICITY ASSAYS
#5SCREENING METHODS FOR TARGETS FOR CANCER THERAPY
#6METHODS FOR PERFORMING MINIATURIZED DYNAMIC ASSAYS USING MICROFLUIDICS AND RELATED SYSTEMS
#7Methods and Products to Screen and Treat Glioblastoma Multiforme and Other Cancers, Including Breast Cancers, Using A Combination of PI3KINASE Inhibitors With Checkpoint Inhibitors
#8METHODS FOR PERFORMING MINIATURIZED DYNAMIC ASSAYS USING MICROFLUIDICS AND RELATED SYSTEMS
#9COMPOSITION FOR PREDICTING OXALIPLATIN DRUG EFFICACY, AND USE THEREOF
#10ANIMAL MODELS OF RECCURRENT HEPATOCELLULAR CARCINOMA AND USES THEREOF
#11NEMATODE-SEALED CAPSULE, METHOD FOR PRODUCING NEMATODE-SEALED CAPSULE, AND USE OF NEMATODE-SEALED CAPSULE
#12METHODS OF TREATING CANCER HAVING AN ACTIVE WNT/BETA-CATENIN PATHWAY
#13DEVICES, SYSTEMS AND METHODS FOR INHIBITING INVASION AND METASTASES OF CANCER
#14METHODS OF ASSESSING OR MONITORING A RESPONSE TO A CELL THERAPY
#15UT2 GENE-DEFICIENT MOUSE MODEL AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR MYELOID LEUKEMIA, USING SAME
#16IMPROVED UnaG FLUORESCENT PROTEIN FOR BiFC ASSAYS
#17METHODS FOR MODULATING A SRC-1 CONDENSATE
#18CELL DEATH BIOMARKER
#19USES OF LABELED HSP90 INHIBITORS
#20METHOD FOR IDENTIFYING ANTI-CANCER AGENTS USING AN IN VITRO CELL CULTURE SYSTEM THAT MAINTAINS CANCER CELL STEMNESS
#21Encapsulated Agents that Bind to MCT-1
#22DROPLET ORGANOID-BASED IMMUNO-ONCOLOGY ASSAYS AND METHODS OF USING SAME
#23DIMETHYLMONOTHIOARSINIC ACID-INDUCED MALIGNANTLY TRANSFORMED CELL LINE OF HUMAN KERATINOCYTES AND USE THEREOF
#24MEASURING ELECTRIC ACTIVITY OF CELLS FOR THE EVALUATION OF METASTATIC POTENTIAL OF CANCER CELLS
#25Methods of measuring signaling pathway activity for selection of therapeutic agents
#26METHODS OF TREATING CANCER PATIENTS WITH RAS NODE OR RTK TARGETED THERAPEUTIC AGENTS
#27METHODS FOR SCREENING CEREBLON MODIFYING COMPOUNDS
#28METHOD AND SYSTEM FOR EVALUATING OPTIMIZED CONCENTRATION TRAJECTORIES FOR DRUG ADMINISTRATION
#29ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES
#30DEVICES, SYSTEMS AND METHODS FOR INHIBITING INVASION AND METASTASES OF CANCER
#31PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#32Non-radioactive cytotoxicity assays
#33PRODUCTION OF CATALYTICALLY ACTIVE TYPE I SULFATASE
#34IFNbeta as a Pharmacodynamic Marker in VSV-IFNbeta-NIS Oncolytic Therapy
#35RADIOMIC SIGNATURE FOR PREDICTING LUNG CANCER IMMUNOTHERAPY RESPONSE
#36CELL-BASED ASSAY FOR DETERMINING THE IN VITRO TUMOR KILLING ACTIVITY OF CHIMERIC ANTIGEN EXPRESSING IMMUNE CELLS
#37DETERMINING TREATMENT RESPONSE IN SINGLE CELLS
#38A METHOD OF PRECISION CANCER THERAPY
#39Lymphovascular invasion bioreactor and methods of making and using same
#40Beta-catenin inhibitors in cancer immunotherapy
#41Method of high throughput screening of chemical compounds suppressing nucleolar hypertrophy
#42Uses of labeled HSP90 inhibitors
#43Methods of assessing or monitoring a response to a cell therapy
#44Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#45Motile sperm domain containing protein 2 and cancer
#46Biomarkers predictive of anti-immune checkpoint response
#47SYSTEM AND METHOD FOR DETERMINING TUMOR INVASIVENESS
#48Method for screening, isolating and purifying analytes
#49CHROMATIN PROTECTIVE THERAPEUTICS AND CHROMATIN HETEROGENEITY
#50Methods of identification and use of nematicide compounds
#51Methods of treating cancer having an active Wnt/β-catenin pathway
#52Recirculating unidirectional perfusion flow devices and methods of use thereof
#53PHARMACEUTICAL ASSOCIATION COMPRISING A GROWTH FACTOR RECEPTOR AGONIST CONJUGATED TO A BIOACTIVE CARRIER FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#54Non-radioactive cytotoxicity assays
#55Cell death biomarker
#56HUMAN EPITHELIAL CELL LINE FOR 3-D MODELIZING OF CANCER AND TREATMENT THEREOF
#57Methods for screening cereblon modifying compounds
#58METHODS OF TREATING A NEUROENDOCRINE TUMOR
#59Devices, systems and methods for inhibiting invasion and metasases of cancer
#60METHODS TO DETECT NON-GENOTOXIC CARCINOGENS USING FLATWORMS
#61Antigen-specific T cell receptors and T cell epitopes
#62Molecular marker for cancer stem cell
#63Methods and reagents for determination and treatment of organotropic metastasis
#64Salivary mRNA Profiling, Biomarkers and Related Methods and Kits of Parts
#65Methods for treating an infectious or neoplastic disease
#66Cancer
#67Methods of measuring signaling pathway activity for selection of therapeutic agents
#68Cap arrangements providing per-well fluidics and gas exchange for advanced microplate, microarray, and microtiter technologies
#69Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness
#70SCREENING METHODS FOR TARGETS FOR CANCER THERAPY
#71Portable reader module, portable reader, and method for quantitative analysis of an assay
#72SYSTEM AND METHOD FOR DETERMINING TUMOR INVASIVENESS
#73BIOLOGICAL SPECIMEN EVALUATION METHODS USING CYTOLOGY AND IMMUNOLOGY
#74SURROGATE FUNCTIONAL BIOMARKER FOR SOLID TUMOR CANCER
#75Methods to detect non-genotoxic carcinogens using flatworms
#76Beta-catenin inhibitors in cancer immunotherapy
#77COMPOSITIONS AND METHODS RELATING TO PROLIFERATIVE DISORDERS
#78METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#79Devices, systems and methods for inhibiting invasion and metastases of cancer
#80Antigen-specific T cell receptors and T cell epitopes
#81Methods for treating an infectious or neoplastic disease
#82Methods of detecting influenza virus
#83Molecular marker for cancer stem cell
#84Anti-p40 antibodies systems and methods
#85Detection method for NTRK3 fusion
#86Methods of treating cancer with atovaquone-related compounds
#873D ADCC NK FACS assay
#88Tissue engineered model
#89Anti-p40 antibodies systems and methods
#90Compositions and methods to prevent cancer with cupredoxins
#91METHOD AND APPARATUS FOR SYSTEMATIC SINGLE CELL TRACKING OF DISTINCTIVE CELLULAR EVENTS
#92Human hepatocyte-like cells and uses thereof
#93Protein expression analyses for identifying genotoxic compounds
#94Genes and proteins associated with angiogenesis and uses thereof
#95Methods of treating cancer having an active Wnt/β-catenin pathway
#96METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING
#97Anti-met therapy for previously diagnosed cancer patients
#98Ex Vivo Culture, Proliferation and Expansion of Primary Tissue Organoids
#99Slide chip for detection sensor of food-borne pathogens and preparation method thereof
#100Advanced microplate, microtiter, and microarray technologies with per-well fluidics, gas exchange, electronic sensors, and imaging for cell culture and other applications
#101Portable blood count monitor
#102Tissue engineered model
#103Methods of detecting influenza virus
#104Diffraction based biosensor containing two diffractive gratings
#105Salivary mRNA profiling, biomarkers and related methods and kits of parts
#106HUMAN EPITHELIAL CELL LINE FOR 3-D MODELIZING OF CANCER AND TREATMENT THEREOF
#107Uses of labeled HSP90 inhibitors
#108METHODS OF DIAGNOSING CANCER USING EPIGENETIC BIOMARKERS
#109In vitro method for predicting in vivo genotoxicity of chemical compounds
#110PEPTIDE PRODRUGS
#111Molecular marker for cancer stem cell
#112Biological assays for the characterization of cells using single-cell tracking and uses thereof
#113Sensitive high throughput method for DNA damage and repair
#114Biomarkers for cancers responsive to modulators of HEC1 activity
#115Assays for determining the effect of an immune cell on a cell from an infectious or neoplastic disease
#116YEAST CELLS EXPRESSING AMYLOID BETA AND USES THEREFOR
#1173D ADCC NK FACS ASSAY
#118Compositions and methods to prevent cancer with cupredoxins
#119Genes and proteins associated with angiogenesis and uses thereof
#120PEPTIDE PRODRUGS
#121Method for Treating Arteriosclerosis
#122TREATMENT OF PROLIFERATIVE DISEASES
#123IN VITRO METHOD FOR PREDICTING WHETHER A COMPOUND IS GENOTOXIC IN VIVO
#124METHOD FOR THE SELECTION OF ENDOTHELIAL CELLS DEATH INDUCERS VIA NETRIN-1 AND ITS APPLICATIONS
#125METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING
#126Cancerous disease modifying antibodies
#127METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS
#128NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#129SCREENING METHOD FOR SUBSTANCE USEFUL AS AGENT FOR TREATING PROSTATE CANCER
#130Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors
#131Molecular marker for cancer stem cell
#132USE OF CXCR4 PROTEIN EXPRESSION ON THE SURFACE OF STEM CELLS AS A MARKER FOR TUMOR TROPIC POTENTIAL
#133Method of generating a dosing schedule using gamma secretase notch biomarkers
#134Method for the identification of carcinogenic compounds
#135SYSTEMIC INSTIGATION SYSTEMS TO STUDY TUMOR GROWTH OR METASTASIS
#136Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase
#137System for the Determination of Molecules Altering the Function of Interferon, Method Therefor and Compounds Altering Interferon Activity
#138Survivin, a protein that inhibits cellular apoptosis, and its modulation
#139Assays for mutagenesis detection
#140Peripheral zone tumor cells, methods for their preparation and use
#141COMPOSITIONS AND METHODS FOR CANCER GENE DISCOVERY
#142MODULATORS OF PARAPTOSIS AND RELATED METHODS
#143Marker Gene For Detection of Tumor Promoter, and Method For Detection of Tumor Promoter
#144Marks as modifiers of the p53 pathway and methods of use
#145In-Vitro Model of the Transformation of Metaplasia to Neoplasia
#146Diagnostic composition and kit for renal cell carcinoma
#147Protein showing enhanced expression in cancer cells
#148HADHs as Modifiers of the p21 Pathway and Methods of Use
#149METHOD FOR ASSESSING POTENTIAL FOR TUMOR DEVELOPMENT AND METASTASIS
#150Methods of monitoring angiogenesis and metastasis in three dimensional co-cultures
#151Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
#152MULTIPLE MECHANISMS FOR MODULATION OF JAK/STAT ACTIVITY
#153SCDs as modifiers of the p53 pathway and methods of use
#154RAPID IN VIVO MODEL FOR ANGIOGENESIS
#155Use of the conserved Drosophila NPFR1 system for uncovering interacting genes and pathways important in nociception and stress response
#156Compositions and methods to prevent cancer with cupredoxins
#157Peptide Prodrugs
#158Gamma secretase notch biomarkers
#159Methods of Analysing Cell Behaviour
#160Methods and compositions for detecting neoplastic cells
#161Thr51 phosphorylated HP 1β protein for the assessment of DNA damage
#162COMPOSITIONS AND METHODS OF MAKING EMBRYONIC STEM CELLS
#163Method for treating vascular disorders
#164Methods to identify compounds useful for tumor sensitization to DNA damage
#165Methods for identifying stem cells based on nuclear morphotypes
#166Methods for identifying candidate anti-tumorigenic agents
#167Cardiac progenitor cells
#168METHODS FOR INDUCING COMPLETE APOPTOSIS OF LIVER CELLS EXPRESSING HBCHI PROTEIN AND SCREENING FOR SUBSTANCES OR GENES THAT INHIBIT THE APOPTOSIS
#169MODULATORS OF PARAPTOSIS AND RELATED METHODS
#170Human dental follicle stem cells and methods for obtaining
#171NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#172Methods of cancer diagnosis and therapy targeted against a cancer stem line
#173NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#174NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#175Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#176Methods of cancer diagnosis and therapy targeted against a cancer stem line
#177NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#178Salivary mRNA profiling, biomarkers and related methods
#179Use of Cxcr4 Protein Expression on the Surface of Stem Cells as a Marker for Tumor Tropic Potential
#180Method of Measuring Cancer Susceptibility
#181REGULATION OF ACHERON EXPRESSION
#182Cancerous Disease Modifying Antibodies
#183Cancerous Disease Modifying Antibodies
#184Cancerous disease modifying antibodies
#185CELL REGULATORY GENES, ENCODED PRODUCTS, AND USES RELATED THERETO
#186MARKs as Modifiers of the p53 Pathway and Methods of Use
#187Thermo-responsive blends and uses thereof
#188Compositions and methods to prevent cancer with cupredoxins
#189CELL SYSTEMS AND METHODS FOR DETECTING PROLIFERATION ACITVITY
#190Modulation of Pericyte Proliferation
#191SCDs As Modifiers of the p53 Pathway and Methods of Use
#192Method for identifying agents which modulate cell growth or survival
#193Materials and Methods for Modulating Cell Motility
#194Using Nonhuman Animal Model, Method of Measuring Transcription Activity Method of Measuring Cell Quantity and Method of Measuring Tumor Volume
#195METHOD AND APPARATUS FOR USING LIGHT TO ENHANCE CELL GROWTH AND SURVIVAL
#196Human schwannoma cell line
#197Gamma secretase notch biomarkers
#198Methods and Compositions for Use in Evaluating and Treating Neoplastic Disease Conditions
#199Method for identifying MLK inhibitors for treatment of neurological conditions
#200Protein showing enhanced expression in cancer cells
#201Methods and systems for evaluating health risk factors by measurement of DNA damage and DNA repair
#202Methods of diagnosing tumors using the G-protein coupled receptor (GPCR), RAI-3
#203Genes and proteins associated with angiogenesis and uses thereof
#204Tumor models employing green fluorescent protein
#205Method of detecting micronucleus in cell
#206XAF genes and polypeptides: methods and reagents for modulating apoptosis
#207Use of caspase inhibitors as a therapeutic agent against radiation-induced injury
#208Secreted neural apoptosis inhibiting proteins
#209HEPATOBLASTS AND METHOD OF ISOLATING SAME
#210Peptides and compositions which modulate apoptosis
#211XAF genes and polypeptides: methods and reagents for modulating apoptosis
#212Patterns for a skeletal system
#213Methods to inhibit growth of prostate cancer cells
#214Immunotherapeutic method of treating neoplastic conditions
#215Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
#216Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
#217Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
#218Methods of cancer diagnosis and therapy targeted against a cancer stem line
#219Methods of cancer diagnosis and therapy targeted against a cancer stem line
#220Methods of cancer diagnosis and therapy targeted against a cancer stem line
#221In vitro platform for screening agents inducing islet cell neogenesis
#222Compositions and Methods for Making Embryonic Stem Cells
#223Modulation of telomere-initiated cell signaling
#224Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
#225Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#226Methods to identify compounds useful for tumor sensitization to DNA damage
#227Method for identifying active anti-apoptosis compounds
#228Growth and differentiation of adult muscle stem cells with activators or inhibitors of Wnt signaling
#229Apoptosis marker antibodies and methods of use
#230Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
#231LIMKs as modifiers of p53 pathway and methods of use
#232High-content screening for drugs against cancer and age-related diseases
#233Cell culture media for mammalian cells
#234Novel compositions and methods in cancer
#235Agents for proliferating pancreatic beta-cells of the islets of langerhans, agents for suppressing apoptosis of said cells, and screening of candidate compounds for these agents
#236Method for diagnosing a pre-neoplastic or neoplastic lesion in transitional epithelial cells
#237Modulation of interaction between Nod1 and Gram-negative bacteria by Nod1 response to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (cagPAI)
#238Methods of cancer therapy targeted against a cancer stemline
#239Survivin, a protein that inhibits cellular apoptosis, and its modulation
#240Survivin, a protein that inhibits cellular apoptosis, and its modulation
#241Methods for identifying stem cells based on nuclear morphotypes
#242Methods for modulating angiogenesis and apoptosis with apelin compositions
#243XAF genes and polypeptides: methods and reagents for modulating apoptosis
#244Human hepatic progenitor cells and methods of use thereof
#245Methods for identifying modulators of transcriptional activator protein interactions
#246Cell regulatory genes, encoded products, and uses related thereto
#247Angiogenic compounds and uses thereof
#248GLUT1 transporters expressed in cancer cells
#249Methods of screening for cell proliferation or neoplastic disorders
#250Oct-4 and GJIC expression as markers for adult human stem cells and cancer cell precursors
#251Suprabasal breast cell with stem cell properties
#252Method for assaying susceptibility to cancer therapy in a subject by assaying for tumors of P53
#253Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
#254HADHs as modifiers of the p21 pathway and methods of use
#255HADHs as modifiers of the p21 pathway and methods of use
#256Chds as modifiers of the p53 pathway and methods of use
#257Tumour markers and biological applications thereof
#258Modulation of pericyte proliferation
#259Bioluminescent assays and cells useful therein
#260Survivin, a protein that inhibits cellular apoptosis, and its modulation
#261Methods and compositions related to a matrix chip
#262High throughput screening method for compounds with non-, pro-, or anti-apoptotic or proliferative or necrotic activity
#263Dgks as modifiers of the p53 pathwha and methods of use
#264Pluripotent embryonic-like stem cells derived from teeth and uses thereof
#265Inhibitors of apoptosis
#266Methods for screening for transdominant effector peptides and RNA molecules
#267Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
#268Comparative ligand mapping from MHC class 1 positive cells
#269Regulation of Acheron expression
#270Methods of treating a neuroendocrine tumor